Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243112 · ClinicalTrials.gov registry record · Phase 4
Effectiveness Study of Different Local Anesthetic Mixtures
A Phase 4 study, sponsored by Scott and White Hospital & Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT01243112: Completed Phase 4 study, sponsored by Scott and White Hospital & Clinic.
NCT01243112 is a Phase 4 study that has completed, run by Scott and White Hospital & Clinic. The registered enrollment target is 25 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01243112, a Phase 4 study, has completed, sponsored by Scott and White Hospital & Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
Purpose and Background The purpose of this research study is to investigate the benefits of mixing lidocaine and bupivacaine for numbing the skin. Lidocaine and bupivacaine are two commonly used medications to numb the skin for minor procedures. Lidocaine has a faster onset. Bupivacaine has a longer duration. They are often combined with epinephrine to increase the length of action. These medications are used to control pain at the time of the operation and to decrease discomfort immediately afterward. Participating in the study involves injection of local anesthetic containing lidocaine, bupivacaine, and lidocaine and bupivacain with epinephrine at 4 sites on the forearm. Your participation will potentially improve the administration of these medications in persons undergoing a variety of procedures. You will be one of approximately 25 healthy volunteer subjects in this research study.
Primary Outcome
The time from onset of local anesthesia until cessation of effect by sensation of sharp measured in 15 minute increments.
Interventions
- DRUG 1% Lidocaine with Epinephrine (1:100,000)
- DRUG 0.25% Bupivacaine with Epinephrine (1:200,000)
- DRUG 0.5% Lidocaine, 0.125 Bupivacaine, and epi (1:150,000)
- DRUG 1% Lidocaine, 0.5% Bupivacaine, and epinephrine (1:150,000)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
What the finished NCT01243112 record still lists
NCT01243112 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which 1% Lidocaine with Epinephrine (1:100,000) is the first listed.
NCT01243112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01243112 about?
NCT01243112 is a clinical study titled "Effectiveness Study of Different Local Anesthetic Mixtures". Purpose and Background The purpose of this research study is to investigate the benefits of mixing lidocaine and bupivacaine for numbing the skin. Lidocaine and bupivacaine are two commonly used medications to numb the skin for minor procedures. Lidocaine has a faster onset. Bupivacaine has a longer...
What is the current status of trial NCT01243112?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2010-05. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01243112?
The interventions under investigation include: 1% Lidocaine with Epinephrine (1:100,000) (DRUG), 0.25% Bupivacaine with Epinephrine (1:200,000) (DRUG), 0.5% Lidocaine, 0.125 Bupivacaine, and epi (1:150,000) (DRUG), 1% Lidocaine, 0.5% Bupivacaine, and epinephrine (1:150,000) (DRUG).
Who is sponsoring clinical trial NCT01243112?
This trial is sponsored by Scott and White Hospital & Clinic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01243112's enrollment target sits among peer trials
25 1669th of 2000 higher than 302 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia